Mirae Asset Global Etfs Holdings »

Context Therapeutics shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $24k 43k 0.55

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Micron Technology (MU)
Apple (AAPL)
Cameco Corporation (CCJ)
Global X Fds Russell 2000 Etf (RSSL)
Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Wheaton Precious Metals Corp (WPM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics